Ulodesine succinate anhydrous, CAS [[1246200-39-4]] Preis auf Anfrage

Produktübersicht

• Artikelname: Ulodesine succinate anhydrous, CAS [[1246200-39-4]] Preis auf Anfrage
• Artikelnummer: TGM-T202983
• Hersteller Artikelnummer: T202983
• Alternativnummer: TGM-T202983-10MG,TGM-T202983-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: DADMe-immucillin H , BCX 4208 , BCX4208 , Ulodesine , BCX-4208

Produktbeschreibung

Ulodesine (also known as BCX4208) is a purine nucleotide phosphorylase (PNP) inhibitor being developed by Biocryst for the treatment of gout. Intended as a once-daily oral therapy, it functions by impacting the purine metabolic pathway upstream of xanthine oxidase to decrease serum uric acid (sUA) levels. Its half-maximal inhibitory concentration (IC(50)) for PNP is 0.5 nM. Currently, BCX-4208 is in early clinical trials to evaluate its potential benefits in treating psoriasis and gout.

Produkteigenschaften

• Molekulargewicht: 323.325
• CAS Nummer: [1246200-39-4]
• Formel: C12H16N4O3 1/2C4H6O4

Bilder

T202983